S-Space

Browse

Author

Jump to a point in the index

Or type in a year

Sort by
In order
Results/Page
Authors/record

Showing results 61 to 120 of 218

Issue Date	Title / Author(s) / Citation	File
2012-01	Clinical outcome of central nervous system metastases from breast cancer: differences in survival depending on systemic treatment Kim, Hee-Jun; Im, Seock-Ah; Keam, Bhumsuk; Kim, Yu-Jung; Han, Sae-Won; Kim, Tae Min; Oh, Do-Youn; Kim, Jee Hyun; Lee, Se-Hoon; Chie, Eui Kyu; Han, Wonshik; Kim, Dong-Wan; Kim, Tae-You; Noh, Dong-Young; Heo, Dae Seog; Park, In Ae; Bang, Yung-Jue; Ha, Sung Whan Journal of Neuro-Oncology, Vol.106 No.2, pp.303-313	DOI
2012-02	Evaluation of the Antitumor Effects and Mechanisms of PF00299804, a Pan-HER Inhibitor, Alone or in Combination with Chemotherapy or Targeted Agents in Gastric Cancer Nam, Hyun-Jin; Ching, Keith A.; Kan, Julie; Kim, Hwang-Phill; Han, Sae-Won; Im, Seock-Ah; Kim, Tae-You; Christensen, James G.; Oh, Do-Youn; Bang, Yung-Jue Molecular Cancer Therapeutics, Vol.11 No.2, pp.439-451	DOI
2012-02	Association of oral mucositis with quality of life and symptom clusters in patients with solid tumors receiving chemotherapy Kim, Jin Won; Cha, Yongjun; Kim, Su-Jung; Han, Sae-Won; Oh, Do-Youn; Lee, Se-Hoon; Kim, Dong-Wan; Im, Seock-Ah; Kim, Tae-You; Heo, Dae Seog; Bang, Yung-Jue Supportive Care in Cancer, Vol.20 No.2, pp.395-403	DOI
2012-02	Augmentation of Chemotherapeutic Infusion Effect by TSU-68, an Oral Targeted Antiangiogenic Agent, in a Rabbit VX2 Liver Tumor Model Kim, Hyo-Cheol; Chung, Jin Wook; Choi, Seung Hong; Im, Seock-Ah; Yamasaki, Yasundo; Jun, Suryoung; Jae, Hwan Jun; Park, Jae Hyung CardioVascular and Interventional Radiology, Vol.35 No.1, pp.168-175	DOI
2012-03	Antitumor activity of HM781-36B, a pan-HER tyrosine kinase inhibitor, in HER2-amplified breast cancer cells Kim, Hye Jin; Kim, Hwang-Phill; Yoon, Young-Kwang; Kim, Maeng-Sup; Lee, Gwan-Sun; Han, Sae-Won; Im, Seock-Ah; Kim, Tae-You; Oh, Do-Youn; Bang, Yung-Jue Anti-Cancer Drugs, Vol.23 No.3, pp.288-297	DOI
2012-03	Down-regulation of mitogen-inducible gene 6, a negative regulator of EGFR, enhances resistance to MEK inhibition in KRAS mutant cancer cells Yoon, Young-Kwang; Kim, Hwang-Phill; Song, Sang-Hyun; Han, Sae-Won; Oh, Do Youn; Im, Seock-Ah; Bang, Yung-Jue; Kim, Tae-You Cancer Letters, Vol.316 No.1, pp.77-84	DOI
2012-04	Phase II trial of preoperative paclitaxel, gemcitabine, and trastuzumab combination therapy in HER2 positive stage II/III breast cancer: The Korean Cancer Study Group BR 07-01 Im, Seock-Ah; Lee, Keun Seok; Ro, Jungsil; Lee, Eun Sook; Kwon, Youngmee; Ahn, Jin-Hee; Ahn, Jin Seok; Kim, Jee Hyun; Kang, Han Sung; Shin, Kyung Hwan; Noh, Dong-Young; Park, In-Ae; Kim, Sung-Bae; Im, Young Hyuck; Ha, Sung Whan Breast Cancer Research and Treatment, Vol.132 No.2, pp.589-600	DOI
2012-04	NVP-BKM120, a novel PI3K inhibitor, shows synergism with a STAT3 inhibitor in human gastric cancer cells harboring KRAS mutations Park, Eunju; Park, Jinah; Han, Sae-Won; Im, Seock-Ah; Kim, Tae-You; Oh, Do-Youn; Bang, Yung-Jue International Journal of Oncology, Vol.40 No.4, pp.1259-1266	DOI
2012-04	Magnetic resonance imaging evaluation of residual ductal carcinoma in situ following preoperative chemotherapy in breast cancer patients Choi, Hei Kyung; Cho, Nariya; Moon, Woo Kyung; Im, Seock-Ah; Han, Wonshik; Noh, Dong-Young European Journal of Radiology, Vol.81 No.4, pp.737-743	DOI
2012-04	Imatinib efficacy by tumor genotype in Korean patients with advanced gastrointestinal stromal tumors (GIST): The Korean GIST Study Group (KGSG) study Kang, Hye Jin; Ryu, Min-Hee; Kim, Kyoung-Mee; Park, Young Soo; Choi, Jene; Ryoo, Baek-Yeol; Kim, Woo Ho; Im, Seock-Ah; Bang, Yung-Jue; Park, Se Hoon; Lee, Jae-Hyuk; Chung, Ik Joo; Bae, Han-Ik; Kim, Jong Gwang; Lee, Kyung Hee; Song, Hong Suk; Kwon, Hyuk-Chan; Baek, Jin Ho; Shin, Dong Bok; Lee, Kyoung Eun; Kang, Yoon-Koo Acta Oncologica, Vol.51 No.4, pp.528-536	DOI
2012-04	Adjuvant chemoradiotherapy after curative resection for extrahepatic bile duct cancer: A long-term single center experience Kim, Kyubo; Chie, Eui Kyu; Jang, Jin-Young; Kim, Sun Whe; Han, Sae-Won; Oh, Do-Youn; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue; Ha, Sung W. American Journal of Clinical Oncology, Vol.35 No.2, pp.136-140	DOI
2012-05	Small node-negative (T1b-cN0) invasive hormone receptor-positive breast cancers: Is there a subpopulation that might have benefit from adjuvant chemotherapy? Park, Yeon Hee; Im, Seock-Ah; Cho, Eun Yoon; Choi, Yoon-La; Lee, Jeong Eon; Nam, Seok Jin; Yang, Jung Hyun; Ahn, Jin Seok; Im, Young-Hyuck Breast Cancer Research and Treatment, Vol.133 No.1, pp.247-255	DOI
2012-07	Gene silencing of EREG mediated by DNA methylation and histone modification in human gastric cancers Yun, Jiyeon; Song, Sang-Hyun; Park, Jinah; Kim, Hwang-Phill; Yoon, Young-Kwang; Lee, Kyung-Hun; Han, Sae-Won; Oh, Do-Youn; Im, Seock-Ah; Bang, Yung-Jue; Kim, Tae-You Laboratory Investigation, Vol.92 No.7, pp.1033-1044	DOI
2012-07	Outcome of Infusional 5-Fluorouracil, Doxorubicin, and Mitomycin-C (iFAM) Chemotherapy and Analysis of Prognostic Factors in Patients with Refractory Advanced Biliary Tract Cancer Lim, Kyu-Hyoung; Han, Sae-Won; Oh, Do-Youn; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue Oncology, Vol.83 No.2, pp.57-66	DOI
2012-07	Breast density change as a predictive surrogate for response to adjuvant endocrine therapy in hormone receptor positive breast cancer Kim, Jisun; Han, Wonshik; Moon, Hyeong-Gon; Ahn, Soo Kyung; Shin, Hee-Chul; You, Jee-Man; Han, Sae-Won; Im, Seock-Ah; Kim, Tae-You; Koo, Hye Ryoung; Chang, Jung Min; Cho, Nariya; Moon, Woo Kyung; Noh, Dong-Young Breast Cancer Research, 14(4):R102	view file DOI
2012-08	Sunitinib synergizes the antitumor effect of cisplatin via modulation of ERCC1 expression in models of gastric cancer Yoon, Young-Kwang; Im, Seock-Ah; Min, Ahrum; Kim, Hwang-Phill; Hur, Hyung-Seok; Lee, Kyung-Hun; Han, Sae-Won; Song, Sang-Hyun; Oh, Do Youn; Kim, Tae-You; Kim, Woo Ho; Bang, Yung-Jue Cancer Letters, Vol.321 No.2, pp.128-136	DOI
2012-09	Phase II clinical trial of induction chemotherapy with fixed dose rate gemcitabine and cisplatin followed by concurrent chemoradiotherapy with capecitabine for locally advanced pancreatic cancer Kim, Jae-Sung; Lim, Joo Han; Kim, Jee Hyun; Im, Seock-Ah; Chie, Eui Kyu; Hwang, Jin-Hyeok; Kim, Tae-You; Bang, Yung-Jue; Ha, Sung Whan; Yoon, Yong Bum Cancer Chemotherapy and Pharmacology, Vol.70 No.3, pp.381-389	DOI
2012-09	Distant metastasis risk stratification for patients undergoing curative resection followed by adjuvant chemoradiation for extrahepatic bile duct cancer Kim, Kyubo; Chie, Eui Kyu; Jang, Jin-Young; Kim, Sun Whe; Han, Sae-Won; Oh, Do-Youn; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue; Ha, Sung W. International Journal of Radiation Oncology Biology Physics, Vol.84 No.1, pp.81-87	DOI
2012-12	The irreversible pan-HER inhibitor PF00299804 alone or combined with gemcitabine has an antitumor effect in biliary tract cancer cell lines Nam, Hyun-Jin; Kim, Hwang-Phill; Yoon, Young-Kwang; Song, Sang-Hyun; Min, Ah-Rum; Han, Sae-Won; Im, Seock-Ah; Kim, Tae-You; Oh, Do-Youn; Bang, Yung-Jue Investigational New Drugs, Vol.30 No.6, pp.2148-2160	DOI
2013-01	Antitumor activity of saracatinib (AZD0530), a c-Src/Abl kinase inhibitor, alone or in combination with chemotherapeutic agents in gastric cancer Nam, Hyun-Jin; Im, Seock-Ah; Oh, Do-Youn; Elvin, Paul; Kim, Hwang-Phill; Yoon, Young-Kwang; Min, Ahrum; Song, Sang-Hyun; Han, Sae-Won; Kim, Tae-You; Bang, Yung-Jue Molecular Cancer Therapeutics, Vol.12 No.1, pp.16-26	DOI
2013-01	Two-year adjuvant imatinib mesylate after complete resection of localized, high-risk GIST with KIT exon 11 mutation Kang, Yoon-Koo; Kang, Byung Woog; Im, Seock-Ah; Lee, Jae-Lyun; Park, Sook Ryun; Kang, Won Ki; Chang, Heung Moon; Kim, Tae Won; Oh, Do-Youn; Jung, Kyung Hae; Ryu, Min-Hee Cancer Chemotherapy and Pharmacology, Vol.71 No.1, pp.43-51	DOI
2013-01	Breast Cancer Molecular Phenotype and the Use of HER2-Targeted Agents Influence the Accuracy of Breast MRI After Neoadjuvant Chemotherapy Moon, Hyeong-Gon; Han, Wonshik; Ahn, Soo Kyung; Cho, Nariya; Moon, Woo Kyung; Im, Seock-Ah; Park, In Ae; Noh, Dong-Young Annals of Surgery, Vol.257 No.1, pp.133-137	DOI
2013-01	KRAS mutation status and clinical outcome of preoperative chemoradiation with cetuximab in locally advanced rectal cancer: A pooled analysis of 2 phase II trials Kim, Sun Young; Shim, Eun Kyung; Yeo, Hyun Yang; Baek, Ji Yeon; Hong, Yong Sang; Kim, Dae Yong; Kim, Tae Won; Kim, Jee Hyun; Im, Seock-Ah; Jung, Kyung Hae; Chang, Hee Jin International Journal of Radiation Oncology Biology Physics, Vol.85 No.1, pp.201-207	DOI
2013-03	Concurrent celecoxib with 5-fluorouracil/epirubicin/cyclophosphamide followed by docetaxel for stages II-III invasive breast cancer: the OOTR-N001 study Chow, Louis W. C.; Tung, Stewart Y.; Ng, Ting-Ying; Im, Seock-Ah; Lee, Min-Hyuk; Yip, Adrian Y. S.; Toi, Masakazu; Glueck, Stefan Expert Opinion on Investigational Drugs, Vol.22 No.3, pp.299-307	DOI
2013-04	Outcomes of surgery aiming at curative resection in good responder to induction chemotherapy for gastric cancer with distant metastases Han, Dong-Seok; Suh, Yun-Suhk; Kong, Seong-Ho; Lee, Hyuk-Joon; Im, Seock-Ah; Bang, Yung-Jue; Kim, Woo-Ho; Yang, Han-Kwang Journal of Surgical Oncology, Vol.107 No.5, pp.511-516	DOI
2013-05	Methylation and microsatellite status and recurrence following adjuvant FOLFOX in colorectal cancer Han, Sae-Won; Lee, Hyun-Jung; Bae, Jeong Mo; Cho, Nam-Yun; Lee, Kyung-Hun; Kim, Tae-Yong; Oh, Do-Youn; Im, Seock-Ah; Bang, Yung-Jue; Jeong, Seung-Yong; Park, Kyu Joo; Park, Jae-Gahb; Kang, Gyeong Hoon; Kim, Tae-You International Journal of Cancer, Vol.132 No.9, pp.2209-2216	DOI
2013-06	RAD51C-Deficient Cancer Cells Are Highly Sensitive to the PARP Inhibitor Olaparib Min, Ahrum; Im, Seock-Ah; Yoon, Young-Kwang; Song, Sang-Hyun; Nam, Hyun-Jin; Hur, Hyung-Seok; Kim, Hwang-Phill; Lee, Kyung-Hun; Han, Sae-Won; Oh, Do-Youn; Kim, Tae-You; O'Connor, Mark J.; Kim, Woo-Ho; Bang, Yung-Jue Molecular Cancer Therapeutics, Vol.12 No.6, pp.865-877	DOI
2013-07	Clinical Usefulness of AJCC Response Criteria for Neoadjuvant Chemotherapy in Breast Cancer Keam, Bhumsuk; Im, Seock-Ah; Lim, Yoojoo; Han, Sae-Won; Moon, Hyeong-Gon; Oh, Do-Youn; Cho, Nariya; Lee, Se-Hoon; Han, Wonshik; Moon, Woo Kyung; Kim, Dong-Wan; Kim, Tae-You; Park, In Ae; Noh, Dong-Young Annals of Surgical Oncology, Vol.20 No.7, pp.2242-2249	DOI
2013-07	OPB-31121, a novel small molecular inhibitor, disrupts the JAK2/STAT3 pathway and exhibits an antitumor activity in gastric cancer cells Kim, Mi-Jung; Nam, Hyun-Jin; Kim, Hwang-Phill; Han, Sae-Won; Im, Seock-Ah; Kim, Tae-You; Oh, Do-Youn; Bang, Yung-Jue Cancer Letters, Vol.335 No.1, pp.145-152	DOI
2013-08	Breast-Conserving Surgery After Tumor Downstaging by Neoadjuvant Chemotherapy is Oncologically Safe for Stage III Breast Cancer Patients Shin, Hee-Chul; Han, Wonshik; Moon, Hyeong-Gon; Im, Seock-Ah; Moon, Woo Kyung; Park, In-Ae; Park, Sung Jun; Noh, Dong-Young Annals of Surgical Oncology, Vol.20 No.8, pp.2582-2589	DOI
2013-09	Survival Outcomes of Breast Cancer Patients Who Receive Neoadjuvant Chemotherapy: Association with Dynamic Contrast-enhanced MR Imaging with Computer-aided Evaluation Yi, Ann; Cho, Nariya; Im, Seock-Ah; Chang, Jung Min; Kim, Seung Ja; Moon, Hyeung-Gon; Han, Wonshik; Park, In-Ae; Noh, Dong-Young; Moon, Woo Kyung Radiology, Vol.268 No.3, pp.662-672	DOI
2013-09	Adjuvant bevacizumab-containing therapy in triple-negative breast cancer (BEATRICE): primary results of a randomised, phase 3 trial Cameron, David; Brown, Julia; Dent, Rebecca; Jackisch, Christian; Mackey, John; Pivot, Xavier; Steger, Guenther G.; Suter, Thomas M.; Toi, Masakazu; Parmar, Mahesh; Laeufle, Rita; Im, Young-Hyuck; Romieu, Gilles; Harvey, Vernon; Lipatov, Oleg; Pienkowski, Tadeusz; Cottu, Paul; Chan, Arlene; Im, Seock-Ah; Hall, Peter S.; Bubuteishvili-Pacaud, Lida; Henschel, Volkmar; Deurloo, Regula J.; Pallaud, Celine; Bell, Richard The Lancet Oncology, Vol.14 No.10, pp.933-942	DOI
2013-11	Serum epidermal growth factor is associated with prognosis and hormone receptor status in patients with HER2-positive metastatic breast cancer treated with first-line trastuzumab plus taxane chemotherapy Kim, Ji-Won; Kim, Jee Hyun; Im, Seock-Ah; Lee, Kyung-Hun; Kim, Jin-Soo; Kim, Tae-Yong; Han, Sae-Won; Jeon, Yoon Kyung; Oh, Do-Youn; Kim, Tae-You; Park, In Ae Cancer Chemotherapy and Pharmacology, Vol.72 No.5, pp.1023-1029	DOI
2013-12	Clinical Implications of VEGF, TGF-beta 1, and IL-1 beta in Patients with Advanced Non-small Cell Lung Cancer Kim, Ji-Won; Koh, Youngil; Kim, Dong-Wan; Ahn, Yong-Oon; Kim, Tae Min; Han, Sae-Won; Oh, Do-Youn; Lee, Se-Hoon; Im, Seock-Ah; Kim, Tae-You; Heo, Dae Seog; Bang, Yung-Jue Cancer Research and Treatment, Vol.45 No.4, pp.325-333	DOI
2013-12	The influence of the treatment response on the impact of resection margin status after preoperative chemoradiotherapy in locally advanced rectal cancer Lee, Joo Ho; Chie, Eui Kyu; Kim, Kyubo; Jeong, Seung-Yong; Park, Kyu Joo; Park, Jae-Gahb; Kang, Gyeong Hoon; Han, Sae-Won; Oh, Do-Youn; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue; Ha, Sung W BMC Cancer Vol.13, pp. 1-9	view file link
2014-01	Adenoid Cystic Carcinoma of the Breast: A Case Series of Six Patients and Literature Review Kim, Miso; Lee, Dae-Won; Im, Jin; Suh, Koung Jin; Keam, Bhumsuk; Moon, Hyeong-Gon; Im, Seock-Ah; Han, Wonshik; Park, In Ae; Noh, Dong-Young Cancer Research and Treatment, Vol.46 No.1, pp.93-97	DOI
2014-02	A Phase II Study of Bevacizumab, Oxaliplatin, and Capecitabine in Patients With Previously Untreated Metastatic Colorectal Cancer A Prospective, Multicenter Trial of the Korean Cancer Study Group Hong, Yong Sang; Lee, Sung Sook; Kim, Kyu-pyo; Lee, Jae-Lyun; Kang, Yoon-Koo; Shin, Sang Joon; Ahn, Joong Bae; Jung, Kyung Hae; Im, Seock-Ah; Kim, Tae-You; Kim, Jee Hyun; Park, Young Suk; Kim, Tae Won American Journal of Clinical Oncology, Vol.37 No.1, pp.19-23	DOI
2014-03	Genetic polymorphisms of SLC28A3, SLC29A1 and RRM1 predict clinical outcome in patients with metastatic breast cancer receiving gemcitabine plus paclitaxel chemotherapy Lee, Soo-Youn; Im, Seock-Ah; Park, Yeon Hee; Woo, Sook Young; Kim, Seonwoo; Choi, Moon Ki; Chang, Wonjin; Ahn, Jin Seok; Im, Young-Hyuck European Journal of Cancer, Vol.50 No.4, pp.698-705	DOI
2014-07	Lamivudine prophylaxis for hepatitis B virus carrier patients with breast cancer during adjuvant chemotherapy Lee, Hyun Jung; Kim, Dae Young; Keam, Bhumsuk; Lee, Jeong Hoon; Han, Sae-Won; Oh, Do-Youn; Yoon, Jung Hwan; Kim, Tae-You; Kim, Yu Jung; Lee, Keun Wook; Kim, Jin-Wook; Jeong, Sook-Hyang; Lee, Jong Seok; Kim, Jee Hyun; Im, Seock-Ah Breast Cancer, Vol.21 No.4, pp.387-393	DOI
2014-07	Safety profile of pertuzumab with trastuzumab and docetaxel in patients from asia with human epidermal growth factor receptor 2-positive metastatic breast cancer: Results from the phase III trial CLEOPATRA Swain, Sandra M.; Im, Young-Hyuck; Im, Seock-Ah; Chan, Valorie; Miles, David; Knott, Adam; Clark, Emma; Ross, Graham; Baselga, Jose Oncologist, Vol.19 No.7, pp.693-701	DOI
2014-07	A New Isolated Mediastinal Lymph Node or Small Pulmonary Nodule Arising during Breast Cancer Surveillance Following Curative Surgery: Clinical Factors That Differentiate Malignant from Benign Lesions Kim, Tae-Yong; Lee, Kyung-Hun; Han, Sae-Won; Oh, Do-Youn; Im, Seock-Ah; Kim, Tae-You; Han, Wonshik; Kim, Kyubo; Chie, Eui Kyu; Park, In-Ae; Kim, Young Tae; Noh, Dong-Young; Ha, Sung Whan; Bang, Yung-Jue Cancer Research and Treatment, Vol.46 No.3, pp.280-287	DOI
2014-08	Correlation of breast cancer subtypes, based on estrogen receptor, progesterone receptor, and HER2, with functional imaging parameters from Ga-68-RGD PET/CT and F-18-FDG PET/CT Yoon, Hai-Jeon; Kang, Keon Wook; Chun, In Kook; Cho, Nariya; Im, Seock-Ah; Jeong, Sunjoo; Lee, Song; Jung, Kyeong Cheon; Lee, Yun-Sang; Jeong, Jae Min; Lee, Dong Soo; Chung, June-Key; Moon, Woo Kyung European Journal of Nuclear Medicine and Molecular Imaging, Vol.41 No.8, pp.1534-1543	DOI
2014-08	Single-Nucleotide Polymorphisms in the Vascular Endothelial Growth Factor Pathway and Outcomes of Patients Treated with First-Line Cytotoxic Chemotherapy Combined with Bevacizumab for Advanced Colorectal Cancer Sohn, Byeong Seok; Park, Seong Joon; Kim, Jeong Eun; Kim, Kyu-pyo; Hong, Yong Sang; Suh, Cheolwon; Kim, Yong Sung; Kim, Seon Young; Im, Seock-Ah; Kim, Sun Young; Kim, Jee Hyun; Ahn, Joong Bae; Park, Young Suk; Kim, Tae Won Oncology, Vol.87 No.5, pp.280-292	DOI
2014-08	Breast Cancer: Early Prediction of Response to Neoadjuvant Chemotherapy Using Parametric Response Maps for MR Imaging Cho, Nariya; Im, Seock-Ah; Park, In-Ae; Lee, Kyung-Hun; Li, Mulan; Han, Wonshik; Noh, Dong-Young; Moon, Woo Kyung Radiology, Vol.272 No.2, pp.385-396	DOI
2014-11	Biomarker Analyses in CLEOPATRA: A Phase III, Placebo-Controlled Study of Pertuzumab in Human Epidermal Growth Factor Receptor 2-Positive, First-Line Metastatic Breast Cancer Baselga, Jose; Cortes, Javier; Im, Seock-Ah; Clark, Emma; Ross, Graham; Kiermaier, Astrid; Swain, Sandra M. Journal of Clinical Oncology, Vol.32 No.33, pp.3753-3761	DOI
2014-12	HER2 Heterogeneity Affects Trastuzumab Responses and Survival in Patients With HER2-Positive Metastatic Breast Cancer Lee, Hee Jin; Seo, An Na; Kim, Eun Joo; Jang, Min Hye; Suh, Koung Jin; Ryu, Han Suk; Kim, Yu Jung; Kim, Jee Hyun; Im, Seock-Ah; Gong, Gyungyub; Jung, Kyung Hae; Park, In Ae; Park, So Yeon American Journal of Clinical Pathology, Vol.142 No.6, pp.755-766	DOI
2015-01	An NMR metabolomics approach for the diagnosis of leptomeningeal carcinomatosis in lung adenocarcinoma cancer patients An, Yong Jin; Cho, Hye Rim; Kim, Tae Min; Keam, Bhumsuk; Kim, Jin Wook; Wen, He; Park, Chul-Kee; Lee, Se-Hoon; Im, Seock-Ah; Kim, Jeong Eun; Choi, Seung Hong; Park, Sunghyouk International Journal of Cancer, Vol.136 No.1, pp.162-171	DOI
2015-01	KRAS mutation is associated with worse prognosis in stage III or high-risk stage II colon cancer patients treated with adjuvant FOLFOX Lee, Dae-Won; Kim, Kyung Ju; Han, Sae-Won; Lee, Hyun Jung; Rhee, Ye Young; Bae, Jeong Mo; Cho, Nam-Yun; Lee, Kyung-Hun; Kim, Tae-Yong; Oh, Do-Youn; Im, Seock-Ah; Bang, Yung-Jue; Jeong, Seung-Yong; Park, Kyu Joo; Park, Jae-Gahb; Kang, Gyeong Hoon; Kim, Tae-You Annals of Surgical Oncology, Vol.22 No.1, pp.187-194	DOI
2015-01	ABCB1 polymorphism as prognostic factor in breast cancer patients treated with docetaxel and doxorubicin neoadjuvant chemotherapy Kim, Hee-Jun; Im, Seock-Ah; Keam, Bhumsuk; Ham, Hye Seon; Lee, Kyung Hun; Kim, Tae Yong; Kim, Yu Jung; Oh, Do-Youn; Kim, Jee Hyun; Han, Wonshik; Jang, In-Jin; Kim, Tae-You; Park, In Ae; Noh, Dong Young Cancer Science, Vol.106 No.1, pp.86-93	DOI
2015-02	A histomorphologic predictive model for axillary lymph node metastasis in preoperative breast cancer core needle biopsy according to intrinsic subtypes Yoo, Su Hyun; Park, In Ae; Chung, Yul Ri; Kim, Hyojin; Lee, Keehwan; Noh, Dong-Young; Im, Seock-Ah; Han, Wonshik; Moon, Hyeong-Gon; Lee, Kyung-Hun; Ryu, Han Suk Human Pathology, Vol.46 No.2, pp.246-254	DOI
2015-03	Histone deacetylase inhibitor, suberoylanilide hydroxamic acid (SAHA), enhances anti-tumor effects of the poly (ADP-ribose) polymerase (PARP) inhibitor olaparib in triple-negative breast cancer cells Min, Ahrum; Im, Seock-Ah; Kim, Debora Keunyoung; Song, Sang-Hyun; Kim, Hee-Jun; Lee, Kyung-Hun; Kim, Tae-Yong; Han, Sae-Won; Oh, Do-Youn; Kim, Tae-You; O’Connor, Mark J O'Connor; Bang, Yung-Jue Breast Cancer Research, 17(1):33	view file DOI
2015-04	Nomogram for predicting breast conservation after neoadjuvant chemotherapy Kim, Min Kyoon; Han, Wonshik; Moon, Hyeong-Gon; Ahn, Soo Kyung; Kim, Jisun; Lee, Jun Woo; Kim, Ju-Yeon; Kim, Taeryung; Lee, Kyung-Hun; Kim, Tae-Yong; Han, Sae-Won; Im, Seock-Ah; Kim, Tae-You; Park, In Ae; Noh, Dong-Young Cancer Research and Treatment, Vol.47 No.2, pp.197-207	DOI
2015-06	A phase I/II trial of second-line chemotherapy with paclitaxel and irinotecan in fluoropyrimidine- and platinum-pretreated patients with advanced gastric cancer Kim, Jin Won; Choi, In Sil; Kim, Yu Jung; Lee, Kyung-Hun; Lee, Keun-Wook; Kim, Tae-Yong; Han, Sae-Won; Kim, Jee Hyun; Kim, Tae-You; Lee, Jong Seok; Bang, Yung-Jue; Im, Seock-Ah; Oh, Do-Youn Cancer Chemotherapy and Pharmacology, Vol.75 No.6, pp.1175-1182	DOI
2015-06	Optimal patient selection for trastuzumab treatment in HER2-positive advanced gastric cancer Ock, Chan-Young; Lee, Keun-Wook; Kim, Jin Won; Kim, Jin-Soo; Kim, Tae-Yong; Lee, Kyung-Hun; Han, Sae-Won; Im, Seock-Ah; Kim, Tae-You; Kim, Woo Ho; Bang, Yung-Jue; Oh, Do-Youn Clinical Cancer Research, Vol.21 No.11, pp.2520-2529	DOI
2015-07	Quality of life (QoL) in metastatic breast cancer patients with maintenance paclitaxel plus gemcitabine (PG) chemotherapy: results from phase III, multicenter, randomized trial of maintenance chemotherapy versus observation (KCSG-BR07-02) Park, Yeon Hee; Jung, Kyung Hae; Im, Seock-Ah; Sohn, Joo Hyuk; Ro, Jungsil; Ahn, Jin-Hee; Kim, Sung-Bae; Nam, Byung-Ho; Oh, Do Youn; Han, Sae-Won; Lee, Soohyeon; Park, In Hae; Lee, Keun Seok; Kim, Jee Hyun; Kang, Seok Yun; Lee, Moon Hee; Park, Hee Sook; Woo, Sook Young; Jung, Sin-Ho; Ahn, Jin Seok; Im, Young-Hyuck Breast Cancer Research and Treatment, Vol.152 No.1, pp.77-85	DOI
2015-07	Distinctive role of SIRT1 expression on tumor invasion and metastasis in breast cancer by molecular subtype Chung, Yul Ri; Kim, Hyojin; Park, Soo Young; Park, In Ae; Jang, Ja June; Choe, Ji-Young; Jung, Yoon Yang; Im, Seock-Ah; Moon, Hyeong-Gon; Lee, Kyung-Hun; Suh, Koung Jin; Kim, Tae-Yong; Noh, Dong-Young; Han, Wonshik; Ryu, Han Suk Human Pathology, Vol.46 No.7, pp.1027-1035	DOI
2015-08	Metabolic characteristics of advanced biliary tract cancer using F-18-fluorodeoxyglucose positron emission tomography and their clinical implications Cho, Kyoung-Min; Oh, Do-Youn; Kim, Tae-Yong; Lee, Kyung Hun; Han, Sae-Won; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue Oncologist, Vol.20 No.8, pp.926-933	DOI
2015-10	The prognostic importance of the number of metastatic lymph nodes for patients undergoing curative resection followed by adjuvant chemoradiotherapy for extrahepatic bile duct cancer Kim, Byoung Hyuck; Kim, Kyubo; Chie, Eui Kyu; Kwon, Jeanny; Jang, Jin-Young; Kim, Sun Whe; Han, Sae-Won; Oh, Do-Youn; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue; Ha, Sung W. Journal of Gastrointestinal Surgery, Vol.19 No.10, pp.1833-1841	DOI
2015-11	Etirinotecan pegol (NKTR-102) versus treatment of physician's choice in women with advanced breast cancer previously treated with an anthracycline, a taxane, and capecitabine (BEACON): a randomised, open-label, multicentre, phase 3 trial Perez, Edith A.; Awada, Ahmad; O'Shaughnessy, Joyce; Rugo, Hope S.; Twelves, Chris; Im, Seock-Ah; Gomez-Pardo, Patricia; Schwartzberg, Lee S.; Dieras, Veronique; Yardley, Denise A.; Potter, David A.; Mailliez, Audrey; Moreno-Aspitia, Alvaro; Ahn, Jin-Seok; Zhao, Carol; Hoch, Ute; Tagliaferri, Mary; Hannah, Alison L.; Cortes, Javier The Lancet Oncology, Vol.16 No.15, pp.1556-1568	DOI
2015-11	Expression of SIRT1 and apoptosis-related proteins is predictive for lymph node metastasis and disease-free survival in luminal A breast cancer Kim, Hyojin; Lee, Kyung-Hun; Park, In Ae; Chung, Yul Ri; Im, Seock-Ah; Noh, Dong-Young; Han, Wonshik; Moon, Hyeong-Gon; Jung, Yoon Yang; Ryu, Han Suk Virchows Archiv, Vol.467 No.5, pp.563-570	DOI

1 2 3 4